Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
19h
Cantor highly bullish on Amgen obesity drug, starts coverage at overweight
Cantor initiated Amgen (AMGN) coverage with an overweight rating, asserting it was a “big believer” in the biotech company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
'Harry Potter' star dies
Helene: How to help
High-end brothel plea
Promotes watch collection
Troops to leave some bases
NC dam failure ‘imminent’
Congressional Gold Medal
NY ballot appeal rejected
Urgent safety alert for 737s
Producing doc on Diddy
50/50 ball ownership suit
Ending password-sharing
Bill to use birth control
Diocese reaches settlement
Van Gogh paintings attacked
Deposition in AI suit
Meta hit with privacy fine
World's oldest cheese found
Boxes to distribute Narcan
Fake Biden robocalls fine
US charges three Iranians
Pleads not guilty
Killer gets life sentence
Dow closes at record high
ISR targets Hezbollah HQ
Fed inflation gauge cools
KY sues Express Scripts
ICE: Convicts roaming free
Houthis attack US warships
Related topics
Amgen
Rocatinlimab
Regeneron
AbbVie Inc.
Myasthenia gravis
Feedback